SCHEMBL5080228

SCHEMBL5080228

Fc1c(Nc2nccn3c(C4CCC4)ncc23)ccc2ccc(Oc3ccccc3)nc12

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 20/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5079103 0.85 IGF1R (0.44) TNK2
SCHEMBL5080691 0.82 IGF1R (0.36) TNK2
SCHEMBL5078897 0.81 TNK2 (0.40) TNK2
SCHEMBL13504863 0.73 TNK2 (0.53) TNK2
SCHEMBL5082839 0.73 TNK2 (0.41) TNK2
SCHEMBL5083250 0.72 TNK2 (0.45) TNK2
SCHEMBL402468 0.71 TNK2 (0.75) TNK2
SCHEMBL5143656 0.70 TNK2 (0.40) TNK2
SCHEMBL2465616 0.67 IGF1R (0.54)
SCHEMBL4762466 0.66 IGF1R (0.36) TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076143-A1 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed